MPC
46
-6
GM
65
7
CCL
51
4
EQT
48
-6
PFE
21
3
MHK
56
-5
NSC
60
4
CA
4
-8
CCI
31
-5
NWS
41
2
TRV
45
3
PRGO
32
3
D
43
2
EXPD
43
-2
NTRS
50
8
SYF
81
7
MNST
47
7
DIS
52
4
STZ
50
5
HAL
60
3
MPC
46
-6
GM
65
7
CCL
51
4
EQT
48
-6
PFE
21
3
MHK
56
-5
NSC
60
4
CA
4
-8
CCI
31
-5
NWS
41
2
TRV
45
3
PRGO
32
3
D
43
2
EXPD
43
-2
NTRS
50
8
SYF
81
7
MNST
47
7
DIS
52
4
STZ
50
5
HAL
60
3
Financhill
Back

Blueprint Medicines Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Sell
30

BPMC
Blueprint Medicines

Last Price:
88.69
Seasonality Move:
10.1%
Sell
22

ALNY
Alnylam Pharmaceuticals

Last Price:
267.99
Seasonality Move:
5.05%
Sell
30
Blueprint Medicines (BPMC) is a Sell

Is Blueprint Medicines a Buy, Sell or Hold?

  • The current Blueprint Medicines [BPMC] share price is $88.58. The Score for BPMC is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • BPMC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
22
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $267.99. The Score for ALNY is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BPMC Stock Price Chart

What is Blueprint Medicines's stock price today?

  • The Blueprint Medicines share price today is $88.58
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BPMC is experiencing slight selling pressure.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $267.99
    The current trend is moderately bearish and ALNY is experiencing slight buying pressure.

BPMC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.96 Sell
Relative Strength Index (14 RSI): 45.15 Sell
Chaikin Money Flow: -108029 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (86.66 - 92.08) Sell
Bollinger Bands (100): (91.1 - 110.3) Sell

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.35 Buy
Relative Strength Index (14 RSI): 49.06 Sell
Chaikin Money Flow: 30222 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (257.4 - 275.32) Buy
Bollinger Bands (100): (181.37 - 279.87) Buy

BPMC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 89.81 Sell
20-day SMA: 88.79 Sell
50-day SMA: 92.93 Sell
200-day SMA: 94.84 Sell
8-day EMA: 89.6 Sell
20-day EMA: 90.04 Sell
50-day EMA: 93.45 Sell
200-day EMA: 91.2 Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 272.8 Sell
20-day SMA: 269.57 Sell
50-day SMA: 266.04 Buy
200-day SMA: 196.91 Buy
8-day EMA: 271.45 Sell
20-day EMA: 270.16 Sell
50-day EMA: 260.28 Buy
200-day EMA: 214.75 Buy

Blueprint Medicines Earnings Growth & BPMC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.52 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.28 per share, and a decrease next year of $0.18 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.47 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.33 per share, and an increase next year of $0.70 per share.

Blueprint Medicines Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):